Status: Not yet recruiting
Phenotype Guided Vasoactive Medication During Kidney Transplantation
The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.
Participants needed: 255
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Jennifer CutlerUpdated: Jun 8, 2026Locations: 1
Eligibility criteria
Adults aged 18 years or older [+2]
Patients unable to provide informed consent [+2]